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ABSTRACT Trifluoperazine, a drug that binds to Ca'-calmodulin and inhibits its interaction
with other proteins, was found to inhibit growth and phagocytosis in a macrophagelike cell
line, J774 .16 . Both effects were reversible and occurred at the same concentrations of drug (25-
50 ptM) that inhibited the activation of cyclic nucleotide phosphodiesterase by calmodulin in
vitro . Fc-mediated phagocytosis was also depressed by W-7, a sulfonamide derivative that
inhibits the activity of Ca"-calmodulin . In contrast, taxol, a drug that stabilizes cellular
microtubules, had no effect on Fc-mediated phagocytosis although it inhibited cell growth at
nanomolar concentrations . The inhibitory effects of trifluoperazine and W-7 on phagocytosis
suggest that calmodulin may be involved in this complex cellular function .
The cloned cell lines J774.2 and J774.16 derive from a macro-
phagelike cell line established in culture from a murine retic-
ulum cell sarcoma, J774 (1) . These cultured lines maintain
certain differentiated macrophagelike functions (2) ; they se-
crete lysozyme and plasminogen activator (3), and migrate and
phagocytize antibody-coated erythrocytes via specific Fc recep-
tors (1, 4) . Since it is feasible to obtain stable variants in some
of these functions, one can analyze macrophage-specific func-
tions using biochemical and genetic tools . For example, var-
iants defective in Fc-mediated phagocytosis (4), cAMP-de-
pendent protein kinase (5) and adenylate cyclase (5) have
facilitated analysis of the modulation of Fc-receptor function
by cyclic AMP (6) . We have previously reported (7) that
trifluoperazine, a phenothiazine that binds to the Ca"-acti-
vated form of calmodulin (8-10) and inhibits its ability to
interact with enzymes such as cyclic nucleotide phosphodies-
terase (8), adenylate cyclase (11), membrane-bound Caz+-ATP-
ase (12-14), myosin light chain kinase and myosin ATPase
(15), and phospholipase A2 (16), inhibits the growth of J774.2 .
This property was used as a strategy for selecting variants in
J774.2 that are defective in calmodulin or in proteins that
interact with calmodulin . To obtain information about the
possible role ofcalmodulin in macrophage function, we studied
the effect of two calmodulin-inhibitory drugs, trifluoperazine,
and the sulfonamide derivative W-7 (13, 15, 17), and taxol, a
drug that promotes microtubule assembly (18), on intact cells
of the J774.16 line .
MATERIALS AND METHODS
Drugs
Trifluoperazine dihydrochloride (Tfp) was a gift from Dr. H. Green ofSmith,
Kline and French and N-(6-aminohexyl)-5-chloro-I-naphthalene sulfonamide
(W-7) was a generous gift from Dr . H . Hidaka (Department of Pharmacology,
School ofMedicine, Mie University, Eobashi Tsu 514, Japan) . Taxolwas obtained
from the National Cancer Institute, Bethesda,Md . Taxol andW-7 were dissolved
in dimethyl sulfoxide at a concentration of 10 mM and stored in the dark at
-20°C . The concentration of dimethyl sulfoxide in each experiment had no
effect oncontrol reactions . Tfp was freshly prepared in phosphate buffered saline
(PBS) and protected from light.
Cells
The cloned cell line J774 .I6 was derived by Muschel et al. (4) from the murine
reticulum cell sarcoma, J774 (1), and adapted to culture by Dr . M. Scharff, Albert
Einstein College of Medicine . Cells were grown in monolayer culture in Dul-
becco's modified Eagle's medium (DME; Gibco Laboratories, Inc., Grand Island,
N.Y.) supplemented with penicillin, streptomycin, 1%glutamine, 1% nonessential
amino acids and 20% heat-inactivated horse serum (Gibco Laboratories, Inc .) .
This supplemented DME is referred to as complete medium. The cells were
maintained at 37C in a humid incubator with an air mixture containing 8%
CO, . Confluent cultures were harvested by vigorously pipetting themedium and
cells . Before initiating a growth curve, cells were centrifuged at 1,000 rpm for 5
minand resuspended in complete medium .
Growth Curves
Cells (2.8 x 10'') were plated onto 60-mm tissue culture dishes in a total
volume of4ml and allowed to attach to the dish for 2 h before addition ofdrug .
At 24-h intervals, themedium was removed and 2 ml ofDME containing 5.9 x
10-M EDTA was added to each plate . The cells were then scraped offthe plate
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determine whether inhibition of growth was reversible, the medium containing
drug was removed, and cells were then washed twice with DME and incubated
in complete medium without drug .
Preparation of Sheep Erythrocytes (SRBC) and
Sheep Erythrocytes Coated with Anti-SRBC
IgG (E[IgG])
SRBC in Alsever's solution (Scott Lab, Fiskeville, R. I .) were washed three
times in DME, resuspended as a5% (vol/vol) suspension in DME and incubated
with an equal volume of Hanks' balanced salt solution containing rabbit antise-
rum to SRBC IgG (Cordis Laboratories, Inc ., Miami, Fla.) . The final dilution of
antiserum was between 1:2,000 and 1 :400 . The mixture was incubated for 30 min
at 37 °C, washed three times in DME, and then resuspended in DME as a 0.5%
(vol/vol) suspension .
Phagocytosis
Approximately 5 x 10" cells in 5 ml of complete medium were plated for 24
h at 37 °C on sterile glass cover slips (13 mm) in 60-mm petri dishes . For the
assay, the cover slips were rinsed once inDMEand covered with a suspension of
E[IgG] . The cells were incubated for 60 min at 37°C, rinsed for 15-20 s in a l:5
dilution of Hanks' solution to lyse the adsorbed erythrocytes and then rinsed for
5 s in undiluted Hanks' solution. A minimum of 100 cells were evaluated for the
number of SRBC ingested. They were scored as 0, 1 . 2, 3, or ?4 erythrocytes per
macrophage.
Ingestion of Latex Beads
Polyvinyltoluene latex beads (2.97 pm diameter) (Dow Diagnostics, Dow
Chemical Co., Indianapolis, Ind.) were washed 10 times with PBS and resus-
pended in complete DME . Cells were grown in 60-mm tissue culture dishes and
incubated with either 0, 10, 25, 30, 45, or 60 AM Tfp for 1 or 3 h at 37°C . The
medium was removed and a suspension of latex beads in complete DME
containing the appropriate concentration of drug was added . After incubation
for l or 3 h at 37°C, the cells were washed four times in DME and fixed as a
monolayer for 45 min in 3% glutaraldehyde inDMEand postfixed in 1% osmium
tetroxide . A graded series of alcohol was used for dehydrating and embedding
the monolayer in Epon. To quantitate phagocytic activity, the plastic-embedded
cells were sectioned at I pm and stained with toluidine blue Oand basic fuchsin .
This made it possible to count the beads present in cell sections . Only cells with
a delineated nucleus and plasma membrane were included . To ensure random
sampling, cells were counted in order from corner to corner and 50 cells were
sampled for each experimental point . For experiments designed to test the
reversibility of the effects ofTfp, cells were incubated in either 0, 10, 25, 30, 45,
or 60 pM ofdrug for 1 h, washed, and allowed to grow in the absence ofdrug for
a 2nd h .A t-h latex bead assay in the absence ofdrug followed.
Lysozyme Assay
Secretion of lysozyme was measured in macrophage-conditioned medium
prepared by plating 3 x 10' cells on 100-mm tissue culture dishes in complete
medium. 2h after plating, 25 pM Tfp or 50 nM taxol wasadded to the medium.
10 h after addition of drug, medium was collected and 200-pl aliquots were
assayed for lysozyme activity. Lysozyme was assayed turbidometrically (19) at
room temperature in a spectrophotometer (Gilford Instrument Laboratories, Inc .,
Oberlin, Ohio) equipped with an automatic recorder . Conditioned medium (200
pl) was added to 0.25mg/ml MicrococcusIvsodeikticus (Worthington Biochemical
Corp ., Freehold, N. J.) in 0.067 M sodium phosphate buffer, pH 6.3, in a final
volume of l ml . The decline in optical density of this solution was followed at
540 nm and the results presented as the change in optical density during the 10
min after addition of conditioned medium.
Immunoglobulin Binding Assay
The binding assay was adapted from that of Unkeless and Eisen (20) and is
described in detail by Schneck et al . (6) . Cells (5 x 10") were plated overnight in
16-mm Linbro wells (Flow Laboratories, Hamden, Ct .) . 2-4h before assay, the
serum-containing medium was replaced by 0.02% lactalbumin hydrolysate (vol/
vol) in DME . At the time of the assay, the medium was aspirated and replaced
with 0.2 ml of a I:1 mixture of 2% bovine serum albumin (BSA) in PBS and
DME containing 1.5 pg of purified '° I-IgG= myeloma protein and varying
amounts of unlabeled IgG:a (6) . After 90 min ofincubation at 4°C, the medium
was withdrawn and the wells were washed three times with ice-cold PBS
containing 50 mM KI . Bound IgG was determined by removing the PBS and
incubating the cells with t ml of 0.25% trypsin for 45 min at 37°C. The trypsin
solution containing the released IgG was removed and assayed for '"'I . Trypsin
treatment released -90% of the SDS-soluble radioactivity . In experiments de-
signed to test the effect of TIP on IgG_ binding, cells were preincubated for 3.5
h with 25 MM drug and the drug was present throughout the ensuing binding
assay . The recovery of cells after the assay was 50% for the drug-treated cells and
900 1o for control cells. Binding was normalized to the final cell count . For the
binding studies reported here, clone J774 .2 rather than J774.16 was used since
the Fc receptors have been characterized in this line (6) and the binding assays
were technically easier with these cells. Fc-mediated phagocytosis in J774.2 is as
inhibited by Tfp as it is in J774 .16 .
Cyclic Nucleotide Phosphodiesterase Activity
The assay mixture (40 pl) consisted of50mM Tris-HCI buffer, pH 7.4, 5 mM
MgCl_, 200 AM cAMP, 2 pCi [''H]cAMP, 2 mM dithiothreitol, 1 mg/ml BSA,
and 20 pl of purified bovine brain cyclic nucleotide phosphodiesterase . Assays
were performed for 10 min at 37 °C in the presence o£ l pg of calmodulin and
either 5 mm CaCl2 or 5 mM EGTA . Reactions were terminated by addition of
a solution (20 pl) containing 12 .5 mM adenosine, 12 .5 mM cAMP, 12.5 mM 5'-
AMP, and0.2mM EDTA . The conversion of cAMP to 5'-AMP and adenosine
was determined by spotting 3 yl ofthe assay mixture on PEI-cellulose thin layer
plates as previously described (21) . The preparation of purified bovine brain
calmodulin and calmodulin-dependent cyclic nucleotide phosphodiesterase have
been reported (7) .
RESULTS
Effects of Tfp and Taxol on Cell Growth
Both Tfp and taxol inhibitedthegrowth of J774.16 . Addition
of 25 yM Tfp to cells 2 h after plating resulted in cell death
within 24 h (Fig . IA) . Inhibition was observed within a very
narrow range of drug concentration; cells grew normally in 20
BM Tfp . Taxol was a more potent inhibitorofcell growth ; 50%
inhibition occurred at -40 nM when observed at 72 hr (Fig .
1 B) .
Fc-mediated Phagocytosis in the Presence of
Tfp, W-7, and Taxol
To assess the effect of drugs on Fc-mediated phagocytosis,
cells that had been plated 16 h previously were incubated with
either Tfp, W-7, or taxol for 1, 2, or 4 h at 37°C in complete
medium . Upon completion of the incubation period, the me-
dium was removed and replaced with 0.1 ml of a 0.5% suspen-
sion of E[IgG], and phagocytosis was assayed as described in
Materials and Methods . The presence of drug during the 1-h
incubation with E[IgG] did not alter the results. As shown in
Figure 2A, Tfp inhibited Fc-mediated phagocytosis in a dose-
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FIGURE 1
￿
Effect of Tfp (A) and taxol ( B) on the growth of ]774.16.
Cell growth was monitored as described in Materials and Methods .
Control, "; drug,O.
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799FIGURE 2 Fc-mediated phagocytosis in J774.16 in
the presence of Tfp (A), W-7 (B), and taxol (C) . Cells
(5 x 105) were plated on glass cover slips in complete
medium . After 16 h, the indicated concentrations of
drug were added for 1 (O), 2 (A), and 4 (0) h. At the
end of the incubation, the cover slips were rinsed
and phagocytosis was assayed as described in Ma-
terials and Methods using a 1 :400 dilution of antise-
rum . The results cited are based on the number of
cells ingesting four or more erythrocytes . 100 mac-
rophages were counted for each experimental point .
Phagocytosis in the control cells varied between 85
and 9.5% .
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Inhibition of calmodulin-stimulated cyclic nucleotide
phosphodiesterase activity by Tfp (O), W-7 (O), and taxol (A) .
Assays were performed as described in Materials and Methods . In
the experiment depicted, the conversion of cyclic AMP to 5'-AMP
was 2 .4% in the absence of calmodulin and 42% in the presence of
calmodulin .
FIGURE 3
dependent manner . At 25 AM Tfp, inhibition was seen after a
l-h exposure of the cells to drug. Fc-mediated phagocytosis
was inhibited 28% after 1 or 2 h with 25 AM Tfp and 67% with
50 AM Tfp. Incubation for 4 h increased inhibition to 33% at
25 AM Tfp and to 82% at 50 AM Tfp . Very little inhibition of
Fc-mediated phagocytosis was seen with W-7 after a 2-h in-
cubation, but 62% inhibition was noted after a 4-h incubation
with 50 AM drug (Fig . 2B) . As shown in Fig . 3, W-7 was also
less effective than Tfp in inhibiting the activation of cyclic
nucleotide phosphodiesterase by Ca=' -calmodulin . On the
otherhand taxol, a drug that has a profound growth-inhibitory
effect on these cells, did not affect phagocytosis (Fig . 2C) even
at concentrations 100-fold in excess of those required to com-
pletely inhibit growth and had little effect on the activation of
cyclic nucleotide phosphodiesterase by Ca`'-calmodulin (Fig .
3) . A light microscope view ofa field of Tfp-treated and control
cells after incubation with E[IgG] is presented in Fig . 4 . Only
a few E[IgG] have been internalized by the drug-treated cells,
whereas most control cells are filled with erythrocytes .
Using monoclonal antibodies, IgG2,- and IgGzh-mediated
phagocytosis were separately analyzed in the presence of 25
BM Tfp and both were found to be depressed . The effect of
Tfp on Fc-receptor expression also was assessed . Both control
cells and cells treated with 25 AM Tfpbound 1251-IgG=, equally,
indicating that Tfp at a concentration that inhibited Fc-medi-
ated phagocytosis did not inhibit the expression of at least one
of the major classes of Fc receptors present on the cell surface
of J774.2 (6).
The effects of Tfp on Fc-mediated phagocytosis and on
growth inhibition are reversible . Cells that were incubated with
25 AM Tfp for 1 h, washed, and grown in fresh complete
medium in the absence ofdrug regained their capacity to carry
800
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Effect of Tfp on Phagocytosis of
Unopsonized Particles
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FIGURE 4
￿
Fc-mediated phagocytosis in J774.16 in the absence (A)
and presence ( B) of Tfp . Cells were plated on glass cover slips and,
in B, incubated with 25 AM Tfp for 2 h before assaying for phago-
cytosis in the presence of 25 pM Tfp . In the absence of drug (A),
most macrophages have ingested several E[IgG] . A typical field was
selected in (B) that clearly demonstrates the inhibition of phago-
cytosis in the presence of Tfp. x 2,700 .
out normal Fc-mediated phagocytosis within l h of drug
removal (Fig . 5) . Such cells continued to grow normally and
gave no indication that they had been exposed to Tfp . The
effect of treatment with 25 AM Tfp for 4 h was also reversible .
Incubation of J774.16 with 25 AM Tfp for 1 or 3 h, plus an
additional hour in the presence of latex beads, depressed
ingestion of the beads (Fig . 6) . As the concentration ofTfpwas80
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FIGURE 5
￿
Reversibility of effects of Tfp on Fc-mediated phagocy-
tosis (A) and cell growth (B) in J774.16 . For phagocytosis, cells were
prepared as described in the legend to Fig . 2 . 25 WM Tfp were added
to the complete medium (O) . After 1 h (1), the medium containing
drug was aspirated from half of the plates and fresh complete
medium minus drug wasadded to these plates (A) . At the indicated
times, Fc-mediated phagocytosis was assayed as described in Ma-
terials and Methods using a 1 :400 dilution of antiserum . For the
reversal of cell growth, cells were grown in the presence of 25 ttM
Tfp for 1 h before the medium was removed (() . Cells were washed
twice with DME, and fresh medium plus 25 gM Tfp (O) or minus
drug (A) was added . A control growth curve (O) carried out com-
pletely in the absence of drug was done at the same time . Cell
growth was monitored as described in Materials and Methods.
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FIGURE 6 Ingestion of latex beads in J774.16 in the presence of
trifluoperazine . Cells (2.5-5 x 10 5 ) were plated in tissue culture
dishes and after 2 h were incubated for either 1 h (O) or 3 h (O)
with the indicated concentrations of Tfp. The cells were assayed
after 1 h for latex bead ingestion in the presence of drug as described
in Materials and Methods . 50 cell sections were counted for each
increased there was progressive inhibition of internalization
(Fig . 6) in a pattern similar to that observed for Fc-mediated
phagocytosis . As in the case of Fc-mediated phagocytosis, the
effect of 25 ,uM trifluoperazine on latex bead ingestion was
reversible .
Effect of Tfp on Lysozyme Secretion
Conditioned medium obtained from cells that had been
incubated with either 25 ,uM Tfp or 50 nM taxol for 10 h was
assayed for lysozyme activity . During a 10-min assay the
change in absorbance at 540 nm was 0.13 for control, 0.14 for
cells treated with 25 ILM Tfp, and 0.16 for cells treated with 50
nM taxol .
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Cells that had been incubated with either 25 ,aM Tfp or 50
nM taxol for 10 h excluded trypan blue to the same extent as
control cells (>90%) . Cells incubated with 25 j,M Tfp for 2 or
5 h showed -25% inhibition of both [ 3H]uridine and ['H]-
thymidine incorporation into TCA-precipitable material (data
not shown), whereas taxol (1 [M) had no effect on macromo-
lecular synthesis during a 2-h incubation . Macromolecular
synthesis was measured as previously described (22) . Thus,
Tfp, unlike taxol, affects either uptake of these nucleic acid
precursors and/or nucleic acid synthesis under the same con-
ditions that it inhibits phagocytosis .
DISCUSSION
One approach to studying complex cellular functions such as
phagocytosis is to select variants defective in different steps of
the process and analyze both their function and pertinent
biochemical pathways . The macrophagelike cell lines derived
from J774 are particularly useful models for the study of
phagocytosis since Fc- and non-Fc-mediated phagocytosis are
easily assayed and stable variants defective in phagocytosis can
be obtained . Although the first step in Fc-mediated phagocy-
tosis appears to be specific binding of an opsonized particle to
macrophage cell surface Fc receptors (23-28) little is known
about how this interaction initiates the series of events that
subsequently result in phagocytosis. In a recently completed
analysis of Fc receptors in phagocytic variants of J774 .2 (6),
one variant was found to be defective in IgG28 phagocytosis
but exhibited normal binding of monomeric IgG2a. It is likely
that this variant was defective in some step distal to the binding
function of the Fc receptor for IgG2a . Isolation of a series of
such variants could be extremely useful in establishing the
biochemical steps involved in phagocytosis . A complementary
approach is to analyze biochemical pathways that may be
involved in phagocytosis . Calmodulin (see references 29-31),
a ubiquitous Ca t+-binding protein, is a component ofa number
of Ca2'-dependent enzymes and may mediate the effects of
Ca
21 on a wide variety of cellular functions such as microtubule
assembly (32) and clathrin recruitment to the cell surface in
receptor-mediated endocytosis ofIgM in cultured human lym-
phoblastoid cells (33) . The discovery that phenothiazines and
W-7 inhibit the activity of calmodulin has provided a tool for
appraising the role of calmodulin in phagocytosis by intact
macrophages. In a study on ingestion of zymosan particles by
rabbit polymorphonuclear leukocytes, Elferink (34) reported
that chlorpromazine inhibited phagocytosis but did not discuss
the possibility that the effect ofthe phenothiazine resulted from
interference with the action ofcalmodulin . We have previously
reported (7) that calmodulin constitutes -1% of the soluble
protein of J774.2 and that it activates bovine brain cyclic
nucleotide phosphodiesterase and is immunologically similar
or identical to calmodulin purified from bovine brain . Extracts
of J774 .2 exhibit Ca"-calmodulin-dependent protein phospho-
rylation and myosin light chain kinase activity and complexes
of ' 2'I-calmodulin and soluble proteins of J774.2 have been
detected by polyacrylamide gel electrophoresis (7) . To evaluate
the potential role of calmodulin in the differentiated macro-
phagelike functions of J774 we studied the effect of the phe-
nothiazine, Tfp, and the sulfonamide derivative, W-7, on phag-
ocytosis in J774.16, a more highly phagocytic clone than J774.2 .
Both drugs were found to reversibly inhibit Fc-mediated as
well as latex bead phagocytosis . The concentration of trifluo-
perazine (25 ,pM) required to inhibit Fc-mediated and non-Fc-
mediated phagocytosis was the same as that needed to inhibit
growth and similar to the concentration that inhibited activa-
tion of bovine brain cyclic nucleotide phosphodiesterase by
calmodulin in vitro. Taxol, a drug that interacts specifically
with microtubules, had no effect on either phagocytosis or the
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tions greatly exceeding those that inhibited the growth of
J774.16 . Although the studies reported herein do not constitute
unambiguous evidence for theinvolvement ofCa"-calmodulin
in phagocytosis, they do suggest the involvement ofcalmodulin
in one or more steps distal to the interaction of particles with
the macrophage cell membrane .
ADDENDUM
W-12 and W-13 are sulfonamide derivatives that act as cal-
modulin antagonists. W-12 lacks a single chloride present in
W-13 and this alteration results in W-12 being a weaker
calmodulin antagonist (Dr . H . Hidaka, personal communica-
tion) . We found that 30 pg/ml W-13 inhibited bovine brain
calmodulin-stimulated cyclic nucleotide phosphodiesterase ac-
tivity by 56% and Fc-mediated phagocytosis in J774.16 by
-65% . W-12 at 40 [tg/ml did not inhibit the phosphodiesterase
and inhibited phagocytosis only 20% . This data provides a
further indication that calmodulin may be involved in phago-
cytosls .
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